ATOMOXETIN ACTAVIS 40 MG CPS DUR 28

What is the maximum co-payment for ATOMOXETIN ACTAVIS?

If the insurance company contributes, the maximum co-payment is 1 721,06 Kč. The maximum pharmacy price is 2 648,24 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does ATOMOXETIN ACTAVIS have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

927,18 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Atomoxetin do síly 60 mg je hrazen u dětí a mladistvých k léčbě hyperkinetické poruchy při neúčinnosti nebo nevhodnosti léčby methylfenidátem. Atomoxetin v síle 40 mg a 60 mg je hrazen rovněž u dospělých pacientů pouze jako iniciační dávka a představuje celkovou denní dávku. Úvodní dávka se má udržovat minimálně 7 dní před titrací dávky směrem nahoru, a to podle klinické odpovědi a snášenlivosti.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe ATOMOXETIN ACTAVIS?

psychiatry, child and adolescent psychiatry, geriatric psychiatry

What is the composition of ATOMOXETIN ACTAVIS?

Atomoxetin-hydrochlorid (45,72 mg), atomoxetin (40 mg), neznámá látka s kódem 17703, neznámá látka s kódem 379, sodná sůl karboxymethylškrobu, želatina, oxid titaničitý, indigokarmín, černý oxid železitý, šelak, propylenglykol, solution amoniaku 10%, hydroxid draselný. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to ATOMOXETIN ACTAVIS?

The medicine belongs to ATC group N06BA09 – ATOMOXETIN. Medicines with the same active substance can be found here.

Who manufactures ATOMOXETIN ACTAVIS?

Actavis Group PTC ehf., Hafnarfjördur (IS)

Is the medicine in shortage?

The latest report from the manufacturer is from 16. 10. 2024. Production was interrupted as of 16. 10. 2024. The stated reason was: Výrobní důvody.
Resumption of supply is expected 31. 3. 2026
The manufacturer lists medicines with the following code as a potential substitute: